Monetta Financial Services Inc Amarin Corp Plcuk Transaction History

Monetta Financial Services Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.13 - $3.69 $361,599 - $1.18 Million	-320,000 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$3.94 - $5.84 $137,900 - $204,400	35,000 Added 12.28%	320,000 $1.63 Million
Q2 2021 Aug 10, 2021	BUY	$4.26 - $6.5 $85,200 - $130,000	20,000 Added 7.55%	285,000 $1.25 Million
Q4 2020 Feb 08, 2021	SELL	$4.04 - $5.31 $80,800 - $106,199	-20,000 Reduced 7.02%	265,000 $1.3 Million
Q3 2020 Nov 05, 2020	BUY	$3.64 - $7.76 $109,200 - $232,800	30,000 Added 11.76%	285,000 $1.2 Million

Q2 2020 Aug 10, 2020	BUY	$4.78 - $8.26 $334,600 - $578,200	70,000 Added 37.84%	255,000 $1.77 Million
Q1 2020 May 12, 2020	SELL	$4.0 - $21.53 $140,000 - $753,550	-35,000 Reduced 15.91%	185,000 $740,000
Q4 2019 Feb 12, 2020	SELL	$13.94 - $24.12 $418,200 - $723,600	-30,000 Reduced 12.0%	220,000 $4.72 Million
Q4 2018 Feb 13, 2019	BUY	$12.41 - $22.98 $2.67 Million - $4.94 Million	215,000 Added 614.29%	250,000 $3.4 Million
Q3 2018 Nov 13, 2018	BUY	$2.45 - $16.27 $85,750 - $569,450	35,000 New	35,000 $569,000

183

87.9M

528K

219K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $282M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Monetta Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Monetta Financial Services Inc with notifications on news.